Biobeat Hosts Expert Panel on Cuffless 24-Hour Blood Pressure Monitoring at AHA 2026

BOCA RATON, Fla. and TEL AVIV, Israel, Oct. 6, 2026 /CourierPR/ -- Biobeat, a company transforming hypertension management, will host an expert panel session and exhibit at the American Heart Association's Hypertension Scientific Sessions 2026. The event, scheduled for October 7-11 in Arlington, Virginia, will focus on the practical application of cuffless 24-hour ambulatory blood pressure monitoring (ABPM) as it becomes a trusted method in hypertension care.

The panel, comprising leading voices in hypertension, will explore the clinical evidence and practical application for cuffless 24-hour ABPM. This technology, which Biobeat is pioneering, offers a single-use, medical-grade, and wireless chest patch that captures 96 blood pressure measurements across a 24-hour period. This data provides healthcare professionals with a comprehensive view of a patient's blood pressure behavior, including during sleep, when accurate readings are most crucial for correct diagnosis and treatment.

According to Biobeat, nearly 50% of U.S. adults are affected by hypertension, and nearly 80% of them do not have it under control. Traditional office readings often miss nighttime blood pressure and cannot reliably distinguish true hypertension from white-coat or masked hypertension, making accurate diagnosis and management challenging. Cuffless monitoring, on the other hand, provides continuous, unobtrusive data collection, enhancing the reliability and effectiveness of hypertension management.

The panel will feature experts from leading institutions, including Gianfranco Parati, MD, from the University of Milano-Bicocca and Scientific Director of Istituto Auxologico Italiano; Ziad Zoghby, MD, MBA, FACP, from the Mayo Clinic; Maria Carolina Delgado-Lelievre, MD, from the Comprehensive Hypertension Center at the University of Miami Health System; and Elias G. Hellou, MD, a cardiologist from Emek Medical Center in Israel and a research collaborator at the Mayo Clinic.

The session will take place on Thursday, October 8, 2026, from 10:00 to 10:30 a.m. ET, in Regency Ballroom A&B at the Hyatt Regency Crystal City. Attendees can visit Biobeat at Booth 13 throughout the event to see the chest patch and physician reporting platform, and to speak with the team.

At the AHA Hypertension Scientific Sessions, Biobeat will showcase its FDA-cleared, medical-grade ABPM platform, which combines a cuffless single-use chest-worn sensor, mobile app, and physician report. This platform supports healthcare professionals in hypertension diagnosis and management, with clinical validation studies published in the American Journal of Hypertension.